A detailed history of Susquehanna International Group, LLP transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 165,063 shares of CTXR stock, worth $480,333. This represents 0.0% of its overall portfolio holdings.

Number of Shares
165,063
Previous 640,539 74.23%
Holding current value
$480,333
Previous $371,000 77.9%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.48 - $1.02 $228,228 - $484,985
-475,476 Reduced 74.23%
165,063 $82,000
Q2 2024

Aug 15, 2024

BUY
$0.58 - $1.03 $365,003 - $648,195
629,316 Added 5607.38%
640,539 $371,000
Q1 2024

May 07, 2024

SELL
$0.6 - $0.9 $77,860 - $116,791
-129,768 Reduced 92.04%
11,223 $10,000
Q4 2023

Feb 14, 2024

BUY
$0.65 - $0.86 $59,461 - $78,671
91,479 Added 184.76%
140,991 $107,000
Q3 2023

Nov 14, 2023

SELL
$0.65 - $1.25 $65,465 - $125,895
-100,716 Reduced 67.04%
49,512 $33,000
Q2 2023

Aug 11, 2023

SELL
$1.08 - $1.65 $334,025 - $510,316
-309,283 Reduced 67.31%
150,228 $180,000
Q1 2023

May 16, 2023

BUY
$0.78 - $1.42 $101,573 - $184,916
130,223 Added 39.55%
459,511 $537,000
Q4 2022

Feb 14, 2023

BUY
$0.79 - $1.28 $216,952 - $351,518
274,624 Added 502.39%
329,288 $260,000
Q3 2022

Nov 14, 2022

SELL
$0.14 - $1.33 $16,971 - $161,226
-121,223 Reduced 68.92%
54,664 $66,000
Q2 2022

Aug 15, 2022

BUY
$0.88 - $1.87 $36,189 - $76,901
41,124 Added 30.52%
175,887 $162,000
Q1 2022

May 16, 2022

SELL
$1.38 - $1.89 $67,905 - $93,001
-49,207 Reduced 26.75%
134,763 $241,000
Q4 2021

Feb 14, 2022

SELL
$1.51 - $2.2 $124,013 - $180,681
-82,128 Reduced 30.86%
183,970 $283,000
Q3 2021

Nov 15, 2021

BUY
$1.74 - $2.6 $102,271 - $152,820
58,777 Added 28.35%
266,098 $540,000
Q2 2021

Aug 11, 2021

BUY
$1.51 - $4.23 $164,973 - $462,144
109,254 Added 111.41%
207,321 $721,000
Q1 2021

May 17, 2021

BUY
$1.04 - $2.34 $101,989 - $229,476
98,067 New
98,067 $175,000
Q1 2020

May 15, 2020

SELL
$0.46 - $1.3 $11,163 - $31,548
-24,268 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$0.42 - $1.15 $10,192 - $27,908
24,268 New
24,268 $25,000

Others Institutions Holding CTXR

About Citius Pharmaceuticals, Inc.


  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $425M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.